Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FISV vs GSK✓SelectedUSD · GSKFISV vs GSK performance historyLatest closeAs of-0.72%11/16
Stock and ETF performance explorer

FISV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-38.0%
GSK return
+46.9%
Excess return
-84.9%
Maximum drawdown
-81.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%-0.1%-0.6%-0.7%
7D-0.3%-1.3%+1.0%-0.2%
30D+33.2%+2.7%+30.4%+32.7%
3M+16.4%+2.7%+13.7%+16.0%
6M+14.4%+3.3%+11.1%+14.0%
YTD-5.7%+6.5%-12.2%-6.3%
1Y-0.2%+10.7%-10.8%-1.0%
3Y-49.3%+64.4%-113.6%-54.7%
5Y-38.0%+46.7%-84.7%-44.3%
All-38.0%+46.9%-84.9%-44.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling